Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.038 | 0.5 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.016 | 0.8 |